Cardiovascular Cell & Gene Therapy Committee

The Cardiovascular Gene & Cell Therapy Committee includes diverse investigators from academia and industry and is focused on the development of novel cell- and gene-based therapies for diseases of the cardiovascular system. Examples of scientific topics of interest include the development of viral and non-viral methods of therapeutic cargo to the heart and vessels, cellular and gene-based strategies to achieve cardiac regeneration and revascularization, and advanced biological therapeutics for diseases including atherosclerosis, heart failure, peripheral vascular disease, pulmonary hypertension, cardiac arrhythmias, and heritable cardiomyopathies. The main mission of the committee is to profile important scientific advances occurring in this rapidly advancing field, including through the development of cardiovascular-related programming for the ASGCT Annual Meeting.